Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine -- Ignore unavailable to you. Want to Upgrade?

To: Don W Stone who wrote (357)	5/11/1998 1:36:00 PM
From: Don W Stone	Read Replies (4) \| Respond to of 507

NVX definitely has momentum going for it. Here is one clear sign. I was told that when ORG started to rally that the shorts went in to stop the momentum. Now I am being told by at least 2 brokers that they did this on friday with NVX and that they, the shorts, are doing the same today. When the bid is 18 1/2 and the ask is 18 5/8 and a 10,000 share block is offered at 18 3/8 it does look that way I guess. Of course the momentum I am really referring to in my opening sentence is about the Company fundamentals and not the daily price action of the stock. My bet is on the momentum of the Company fundamentals. This Company will be going at the rate of one new "blockbuster drug" about every 12-18 months or so. Adult aP is definitely not factored into the stock at this point yet the market potential is conceivably four times that of infant DTaP. With Adult Pertussis the potential for the US and Europe is on the order of 50 million does annually. That is a big number. Today NVX leads in getting this vaccine to the market. Now as to shorting NVX today, I consider it an act of desperation and one that will only benefit those that are long NVX. :-} The stream of positive news that is forthcoming out of NVX will make my point very clear. :-}